USRE31588EExpiredUtility
Imidazolylmethylthioethyl alkynyl guanidines
Priority: Jun 3, 1977Filed: Jun 16, 1981Granted: May 22, 1984
Est. expiryJun 3, 1997(expired)· nominal 20-yr term from priority
C07C 323/44C07D 277/64C07D 233/64
11
PatentIndex Score
1
Cited by
46
References
10
Claims
Abstract
Compounds of the formula ##STR1## wherein R 1 is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms, inclusive, and nontoxic pharmaceutically acceptable acid addition salts thereof, are potent anti-ulcer agents.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A compound of the formula ##STR24## wherein R 1 is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms, inclusive, or a nontoxic pharmaceutically acceptable acid addition salt thereof.
2. A compound of the formula ##STR25## wherein R 4 is hydrogen or methyl, or a nontoxic pharmaceutically acceptable acid addition salt thereof.
3. A compound of the formula ##STR26## wherein R 4 is hydrogen or methyl and n is an integer of from 1 to 6, inclusive, or a noxtoxic pharmaceutically acceptable acid addition salt thereof. .[.
4. A compound of the formula ##STR27## wherein R 4 is hydrogen or methyl, or a nontoxic pharmaceutically acceptable acid addition salt thereof..].
5. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-propargylguanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof.
6. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-propargylguanidine.
7. A nontoxic pharmaceutically acceptable salt of N-cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-propargylguanidine.
8. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(2-butyn-1-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof.
9. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(3-butyn-1-yl)guanidine or a nontoxic pharmaceutically acceptable salt thereof.
10. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(4-pentyn-1-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof. .[.11. N-Cyano-N-'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(2-methyl-3-butyn-2-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition
salt thereof..]. 12. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(3-butyn-2-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof.Join the waitlist — get patent alerts
Track USRE31588E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.